GlassScriptPhysician profile
Jennifer Schaefer
NPI 1396294153
$1,439.07
in general payments reported to CMS, 2019-2025
10 companies · $358 in 2025
The $358 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $40.84 · 2022: $58.76 · 2023: $500 · 2024: $481 · 2025: $358.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,240 · Education: $99.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,240.47 |
| Education | $99.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $861.11 | 2023-2025 | Stelara, Tremfya, Simponi Aria |
| Janssen Scientific Affairs, LLC | $130.18 | 2022-2024 | Stelara |
| Phathom Pharmaceuticals, INC. | $120.46 | 2024 | Voquezna |
| Takeda Pharmaceuticals U.S.A., INC. | $78.70 | 2023-2025 | Entyvio |
| Astrazeneca Pharmaceuticals LP | $70.06 | 2023 | Breztri |
| Abbvie INC. | $56.03 | 2021-2025 | |
| Lilly USA, LLC | $45.57 | 2021-2024 | Omvoh |
| Ferring Pharmaceuticals INC. | $37.26 | 2023 | Rebyota |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $24.33 | 2025 | Xifaxan |
| Braintree Laboratories, INC. | $15.37 | 2023 | Sutab |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jennifer Schaefer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.